Syneron Medical reports me brand FDA cleared for expanded indication Syneron Medical and Iluminage Beauty announced that the me brand of home-use hair removal systems received an expanded indication for use from the Food and Drug Administration for permanent reduction in hair growth. The me brand is owned and sold by Iluminage Beauty, Syneron's global joint venture in home beauty devices.
News For ELOS From The Last 14 Days
Check below for free stories on ELOS the last two weeks.
Syneron Medical recommend following FDA clearance at Maxim Maxim recommends investors continue buying shares of Syneron Medical following the FDA clearance of UltraShape. Maxim says UltraShape expands the base of body shaping treatments that physicians may use with complimentary Syneron systems and it keeps a Buy rating on the stock with a $16 price target.